STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be use d for the research of acute myeloid leukaemia (AML)[1][2]. 1 * 25 mg
STM2457 is a first-in-class, highly potent, selective and orally active METTL3 inhibitor with an IC50 of 16.9 nM. STM2457 can be use d for the research of acute myeloid leukaemia (AML)[1][2]. 1 * 25 mg